IMA Advisory Services’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.28K Buy
131
+45
+52% +$1.93K ﹤0.01% 850
2026
Q1
$3.27K Sell
86
-4
-4% -$190 ﹤0.01% 509
2025
Q4
$4.58K Buy
+90
New +$4.6K ﹤0.01% 448
2023
Q2
– Sell
-4
Closed -$319 – 314
2023
Q1
$319 Hold
4
– – ﹤0.01% 296
2022
Q4
$271 Hold
4
– – ﹤0.01% 323
2022
Q3
$0 Buy
+4
New +$214 ﹤0.01% 397
2019
Q2
– Sell
-134
Closed -$4K – 300
2019
Q1
$4K Hold
134
– – ﹤0.01% 245
2018
Q4
$3K Hold
134
– – ﹤0.01% 280
2018
Q3
$3K Sell
134
-214
-61% -$5.22K ﹤0.01% 283
2018
Q2
$8K Buy
+348
New +$8.27K ﹤0.01% 284

Other funds holding NVO

IMA Advisory Services's NVO Position: Q2 2026 in Review

IMA Advisory Services increased its Novo Nordisk (NVO) stake by 52% in Q2 2026, buying an estimated $1.93K and bringing the position to 131 shares worth $6.28K. The position accounts for ﹤0.01% of the portfolio, ranked #850.

IMA Advisory Services first reported a position in NVO in Q2 2018 and has held it in 10 quarters since. The position peaked at $8K in Q2 2018. 1,356 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • IMA Advisory Services held 131 shares of Novo Nordisk worth $6.28K as of Q2 2026.
  • IMA Advisory Services bought 45 Novo Nordisk shares in Q2 2026, an estimated $1.93K.
  • Novo Nordisk made up ﹤0.01% of IMA Advisory Services's portfolio in Q2 2026, its #850 holding.
  • IMA Advisory Services first reported a position in Novo Nordisk in Q2 2018 and has held it in 10 quarters since.
  • IMA Advisory Services's Novo Nordisk position peaked at $8K in Q2 2018.
  • 1,356 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on IMA Advisory Services's 13F filing for Q2 2026, filed 10 Aug 2026.